Specially invited speakers, among them some of the world's finest researchers, will speak about their latest achievements and research on colorectal cancer. The lectures are open to all interested in advances within research on colorectal cancer, and the theme for this meeting is Genomic stability and instability in cancer.
WTCHG Director, Prof Peter Donnelly, spoke as part of a Prof Brian Cox chaired panel for the Royal Society's event "Science Matters - Machine Learning and Artificial intelligence".
Wellcome has announced funding of £118 million to 14 major research centres, including three centres based in Oxford. The Wellcome Centre for Human Genetics, based in Oxford for 22 years, has played a pioneering role in the progress and success of human disease genetics and mechanism research.
We have now made available additional Oxford Nanopore sequencing data, adding raw data files to the existing dataset.
Scientists from the Wellcome Trust Centre for Human Genetics (WTCHG) have used Oxford Nanopore Technologies MinION sequencing devices to sequence two human DNA samples, in an exploration of the capabilities of the pocket-sized, USB-powered sequencing devices.
Dr Rose Wilson, of the Green lab, has written of their experience running a stall at the 'Science Uncovered' late-night event at the Natural History Museum, London.
Dr. Claire Palles, part of the Tomlinson group based at the WTCHG, has been highlighted by the Nuffield Department of Medicine as part of their series of video interviews. Hear more about how Dr. Palles uses whole genome sequencing with the aim of discovering genetic variants that affect susceptibility to colorectal cancer and Barrett’s oesophagus.
Clinicians and researchers are preparing to light Oxford’s Magdalen Tower blue to mark World Diabetes Day – and have invited patients and visitors to then learn more at an open day about the condition at the Churchill Hospital.
Research involving the Tomlinson group has been published in "Cancer Cell" looking at the effect of a gene IDH1R132H in the development of tumours in glial cells, such as the brain. They found that expression of IDH1R132H in the adult mouse brain causes features of glioma development, and a gene expression profile overlapping that of human glial tumours.
An international collaboration, including researchers jointly from the Wellcome Trust Centre of Human Genetics and the Wellcome Trust Sanger Institute, carried out a genome-wide association study on approximately 300 Plasmodium falciparum samples from Cambodia to study the genetic basis behind piperaquine resistance.